SCHEMBL20206507

SCHEMBL20206507

CCC(C)CNCCNCCNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19133264 0.98
SCHEMBL5038322 0.90 ALDH1A1 (0.30)
SCHEMBL4909539 0.90 ALDH1A1 (0.30)
SCHEMBL4916655 0.90 ALDH1A1 (0.30)
SCHEMBL4915543 0.87 TSHR (0.30)
SCHEMBL13815124 0.84 EPHX1 (0.42)
SCHEMBL10000679 0.82 EPHX1 (0.46)
SCHEMBL10045236 0.80 CYP2C19 (0.46)
SCHEMBL4917435 0.79 CA12 (0.50)
SCHEMBL19836687 0.79 LMNA (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018097403-A1 CONJUGATE OF ANTICANCER DRUG AND DIOSGENIN, PREPARATION METHOD THEREFOR, AND ANTICANCER COMPOSITION CONTAINING SAME 전남대학교산학협력단 2018-05-31 WO disclosed